Screener
ResMed Inc. RMD EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ResMed Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: ResMed Inc.’s 10-K, filed August 13, 2026.
- Filed
- Aug 13, 2026, 5:17 PM EDT
- Fiscal year
- FY2026
- Accession
- 0000943819-26-000047
| Line item | June 30, 2026 | June 30, 2025 | June 30, 2024 |
|---|---|---|---|
| Income before income taxes | 1,919,416 | 1,677,566 | 1,264,798 |
| Income taxes (note 12) | 396,123 | 276,843 | 243,847 |
| Net income | $1,523,293 | $1,400,723 | $1,020,951 |
| Basic earnings per share (note 11) | $10.47 | $9.55 | $6.94 |
| Diluted earnings per share (note 11) | $10.43 | $9.51 | $6.92 |
| Dividend declared per share | $2.40 | $2.12 | $1.92 |
| Basic shares outstanding (000's) | 145,523 | 146,716 | 147,021 |
| Diluted shares outstanding (000's) | 146,054 | 147,340 | 147,550 |
ITEM 8 CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is ResMed Inc.'s EPS (diluted)?
- ResMed Inc. (RMD) reported EPS (diluted) of $2.64 in Q2 2026.
- How has ResMed Inc.'s EPS (diluted) changed year-over-year?
- ResMed Inc.'s EPS (diluted) increased by 2.3% year-over-year, from $2.58 to $2.64.
- What is the long-term trend for ResMed Inc.'s EPS (diluted)?
- Over 4 years (2022 to 2026), ResMed Inc.'s EPS (diluted) has grown at a 18.4% compound annual growth rate (CAGR), from $5.31 to $10.43.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about ResMed Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude